Laurence W. Lytton Increases Stake in DNA X, Inc. to 8.1%

2026-05-15SEC Filing SCHEDULE 13G/A (0000935836-26-000256)

Laurence W. Lytton has filed a Schedule 13G/A (Amendment No. 7) for DNA X, Inc. (ticker: SONM), reporting a beneficial ownership of 120,357 shares of Common Stock. This represents an 8.1% ownership stake in the company based on 1,488,268 shares outstanding as of April 21, 2026. Of the total shares, Lytton holds sole voting and dispositive power over 81,469 shares and shared voting and dispositive power over 38,888 shares. The filing notes that the reported total excludes warrants to purchase an additional 22,222 shares due to a 4.99% beneficial ownership limitation. This filing marks an increase from a previously reported 0.0% position, indicating a significant new or re-established holding. The reporting person certified that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. The event triggering this filing occurred on March 31, 2026.